GAROFALO HEALTH CARE S.P.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.44 EUR | -0.37% |
|
+6.67% | +17.24% |
| May. 15 | Garofalo Health Care in the quarter increases profit and revenues | AN |
| May. 15 | Garofalo Health Care S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +17.24% | 526M | B | ||
| -25.47% | 15B | B+ | ||
| -1.80% | 11.99B | B | ||
| +3.48% | 11.7B | B+ | ||
| +27.17% | 8.59B | B | ||
| -6.29% | 7.5B | A- | ||
| +6.08% | 6.71B | B- | ||
| +0.89% | 6.02B | D | ||
| -4.31% | 4.28B | - | ||
| +11.12% | 4.04B | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- GHC Stock
- Ratings Garofalo Health Care S.p.A.
